These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 21135485)

  • 41. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization.
    Schaible J; Stroszczynski C; Beyer LP; Jung EM
    Clin Hemorheol Microcirc; 2019; 73(1):95-104. PubMed ID: 31561349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. First results of endocavity evaluation of the microvascularization of malignant prostate tumors using contrast enhanced ultrasound (CEUS) including perfusion analysis: first results.
    Jung EM; Wiggermann P; Greis C; Eder F; Ehrich J; Jung W; Schreyer AG; Stroszczynski C; Ganzer R
    Clin Hemorheol Microcirc; 2012; 52(2-4):167-77. PubMed ID: 22975940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.
    Gao Y; Zheng DY; Cui Z; Ma Y; Liu YZ; Zhang W
    World J Gastroenterol; 2015 Sep; 21(36):10418-26. PubMed ID: 26420968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Characterization of hepatic tumors with contrast-enhanced ultrasound and digital grey-scale analysis].
    Lemke AJ; Chopra SS; Hengst SA; Brinkmann MJ; Steinmüller T; Felix R
    Rofo; 2004 Nov; 176(11):1607-16. PubMed ID: 15497079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving the follow up after EVAR by using ultrasound image fusion of CEUS and MS-CT.
    Clevert DA; Helck A; D'Anastasi M; Gürtler V; Sommer WH; Meimarakis G; Weidenhagen R; Reiser M
    Clin Hemorheol Microcirc; 2011; 49(1-4):91-104. PubMed ID: 22214681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of computed tomography (CT) and contrast-enhanced ultrasound (CEUS) for the quantitative evaluation of an ablation defect following radiofrequency ablation of malignant liver lesions.
    Bruenn K; Beyer L; Haimerl M; Pregler B; Stroszczynski C; Jung EM; Wiggermann P
    Clin Hemorheol Microcirc; 2017; 67(3-4):445-451. PubMed ID: 28885212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contrast-enhanced ultrasonography (CEUS) using early dynamic in microcirculation for localization of pathological parathyroid glands: first-line or complimentary diagnostic modality?
    Hornung M; Jung EM; Stroszczynski C; Schlitt HJ; Agha A
    Clin Hemorheol Microcirc; 2011; 49(1-4):83-90. PubMed ID: 22214680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
    Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
    Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Value of color Doppler ultrasound in preoperative planning of the resection of liver tumors].
    Bunk A; Stoelben E; Köhler T; Nagel M; Seager HD
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():428-30. PubMed ID: 9574172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging.
    Giorgio A; De Stefano G; Coppola C; Ferraioli G; Esposito V; Di Sarno A; Giorgio V; De Stefano M; Sangiovanni V; Liorre G; Del Viscovo L
    Anticancer Res; 2007; 27(6C):4263-9. PubMed ID: 18214030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.
    Forner A; Vilana R; Bianchi L; Rodríguez-Lope C; Reig M; García-Criado MÁ; Rimola J; Solé M; Ayuso C; Bru C; Bruix J
    J Hepatol; 2015 Jan; 62(1):150-5. PubMed ID: 25173969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma.
    Martie A; Sporea I; Popescu A; Sirli R; Dănilă M; Serban C; Ardelean M; Bota S; Sendroiu M; Chisevescu D
    Med Ultrason; 2011 Jun; 13(2):108-13. PubMed ID: 21655536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA.
    Seitz K; Strobel D
    Ultraschall Med; 2016 Jun; 37(3):229-32. PubMed ID: 27276056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment response evaluation with three-dimensional contrast-enhanced ultrasound for liver cancer after local therapies.
    Xu HX; Lu MD; Xie XH; Xie XY; Kuang M; Xu ZF; Liu GJ; Wang Z; Chen LD; Lin MX
    Eur J Radiol; 2010 Oct; 76(1):81-8. PubMed ID: 19500929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dynamic evaluation and quantification of microvascularization during degradable starch microspheres transarterial Chemoembolisation (DSM-TACE) of HCC lesions using contrast enhanced ultrasound (CEUS): a feasibility study.
    Wiggermann P; Wohlgemuth WA; Heibl M; Vasilj A; Loss M; Schreyer AG; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2013; 53(4):337-48. PubMed ID: 22555335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultrasound-arterioportography (US-AP): A new technical approach to perform detection of liver lesions.
    Zorger N; Jung EM; Schreyer AG; Heiss P; Mueller-Wille R; Wiest R; Feuerbach S; Rennert J
    Clin Hemorheol Microcirc; 2010; 46(2-3):117-26. PubMed ID: 21135487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Image fusion in the management of thermal tumor ablation of the liver.
    Clevert DA; Paprottka PM; Helck A; Reiser M; Trumm CG
    Clin Hemorheol Microcirc; 2012; 52(2-4):205-16. PubMed ID: 22960300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
    Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
    Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contrast-Enhanced Ultrasound of Focal Liver Lesions.
    D'Onofrio M; Crosara S; De Robertis R; Canestrini S; Mucelli RP
    AJR Am J Roentgenol; 2015 Jul; 205(1):W56-66. PubMed ID: 26102419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma < or =2 cm.
    Xu HX; Xie XY; Lu MD; Liu GJ; Xu ZF; Zheng YL; Liang JY; Chen LD
    J Clin Ultrasound; 2008 Jun; 36(5):257-66. PubMed ID: 18088056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.